SynthesisClinical drug investigation2022

Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Devarapalli Ranjani Durga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.